2008 Annual Meeting
Presentations from the ASENT 10th Annual Meeting:
- 7th Advocacy Forum
- Clinical Trials Class (Morning and Afternoon)
- Friday and Saturday Morning Symposia
- Friday Afternoon General Session
To view a session, click 
to view
a PowerPoint slide presentation, 
to hear the audio,
and 
to view a video.
Thursday, March 6, 2008
Clinical Trails In Neurotherapeutics
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Phases of Therapeutic Development |
Virinder Nohria, M.D., Ph.D |
1hr. 19min. 51sec. |
|
|
|
| Placebo: Ethics and Alternatives |
Samuel Frank, M.D. |
1hr 19min. 51sec. |
|
|
|
| Fundamentals of Clinical Trials Endpoints |
Betsy Garofalo M.D. |
12hr. 7min. 21sec. |
|
|
|
| Statistical Considerations in Clinical Trials |
Susan S. Ellenberg, Ph.D. |
1hr. 7min. 21sec. |
|
|
|
| Dose Selection in Pharmaceutical Development |
Eliseo Salinas, M.D., Msc |
48min. 07sec. |
|
|
|
| Clinical Pharmacology in Drug Development |
Ramana S. Uppoor, R.Ph., Ph.D. |
|
|
|
|
| Equivalence, Similarity, and Non-Inferiority |
Marc K. Walton, M.D., Ph.D. |
54min. 58sec. |
|
|
|
| Data Safety Monitoring Board |
Jennifer Schumi, Ph.D |
|
|
|
|
Thursday, October 29, 2009
Seventh Annual Advocacy Forum: Patient-Reported Outcome Data: Will this improve therapeutic Development
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Regulary and Industry Perspective |
Toni Stifano and Chris Leibman |
54min. 7sec. |
|
|
|
| Investigator Perspective |
Robert Griggs, M.D. |
17min. 30sec. |
|
|
|
Thursday, March 6, 2008
Roundtable Discussion
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Why Things Are The Way They Are- Monitoring, Data Chain Of Custody, Crfs And Other Mysteries Revealed |
Christopher C. Gallen, M.D., Ph.D. |
|
|
|
|
Dinner Symposium: Post-Marketing Surveillance
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Is FDA Failing Us or are we Failing FDA? |
Jonathan C. Javitt, M.D.,M.P.H |
35min. 22sec. |
|
|
|
| Magic Bullets and Miracle Cures? The Reality Of Post-Marketing Surveillance |
Janice K. Bush, M.D. |
12min. 59sec. |
|
|
|
| Post-Marketing Surveillance: One Division Director’s View |
Russell Katz, M.D |
37min. 5min. |
|
|
|
Friday, March 7, 2008
Symposium: Clinical Trails, Treatments and Tribulations in Neuroprotection and Disease Modification
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Clinical Trials in Acute Stroke |
Sean Savitz, M.D. |
25min. 45sec. |
|
|
|
| Clinical Trials In Alzheimer’s Disease |
Paul S. Aisen, M.D. |
41min. 46sec. |
|
|
|
| Clinical Trials in ALS |
Merit E. Cudkowicz, M.D. |
28min. 2sec. |
|
|
|
| Enhancing Recover after Acute Ischemia |
Steven C. Cramer, M.D. |
23min. 35sec. |
|
|
|
| Advances In ALS Therapy: A Brave New World by Preclinical Studies |
Robert Brown, Jeffrey Rothstein, Tim Miller, Don Cleveland, Bob Ferrante, Terry Heiman Patterson & Clinical Studies - Jeremy Shefner, David Schoenfeld , Tim Miller, Northeast ALS Consortium |
57min. 1sec. |
|
|
|
General Session: How to Measure Long-Term Outcomes
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Measuring Long-Term Efficacy In Epilepsy Trials |
Jacqueline A. French M.D. |
|
|
|
|
| Long-Term Outcomes after Acute Stroke Treatment |
Larry B. Goldstein, M.D. |
20min. 38sec. |
|
|
|
| Long Term Outcomes In Alzheimer’s Disease |
Eric Siemers, M.D. |
20min. 58sec. |
|
|
|
| Neurorehabilitation Long-Term Outcomes |
George F. Wittenberg, M.D., Ph.D |
31min. 42sec. |
|
|
|
Saturday, March 8, 2008
Symposium: The Science of Multi-potential Therapies - Which Indication Do You Pursue?
| Title |
Speaker(s) |
Duration |
Presentation |
Audio |
Video |
| Putative Multimodal Neuroprotective, Neurorestorative and Symptomatic Drugs For Neurodegenerative Disorders |
Moussa. B.H. Youdim |
40min. 20sec. |
|
|
|
| Botulinum Toxin's Serendipitous Targets by The Science of Multi-Potential Therapies |
Clare J. Fowler |
31min. 20sec. |
|
|
|
| Multi-Potential Therapies Which Indication Do You Go After? - Antiseizure Drugs As Neuromodulators |
Roy Twyman |
40min. 48sec. |
|
|
|
| Clinical Development of Marketed Drugs for New Uses |
Russell Katz, M.D. |
54min. 39sec. |
|
|
|
